ChitogenX Inc.
CHNXF
$0.0071
-$0.0039-35.46%
| 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | 10/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -26.54% | -54.66% | -105.46% | -25.75% | -55.12% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.29% | -63.98% | -100.47% | -36.68% | -70.47% |
| Operating Income | -5.29% | 63.98% | 100.47% | 36.68% | 70.47% |
| Income Before Tax | 23.12% | 20.68% | -261.59% | 78.83% | 58.63% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 23.12% | 20.68% | -261.59% | 78.83% | 58.63% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 23.12% | 20.68% | -261.59% | 78.83% | 58.63% |
| EBIT | -5.29% | 63.98% | 100.47% | 36.68% | 70.47% |
| EBITDA | -6.08% | 64.86% | 101.33% | 36.77% | 71.02% |
| EPS Basic | 26.39% | 27.50% | -200.00% | 86.94% | 73.63% |
| Normalized Basic EPS | 26.67% | 28.00% | -200.00% | 78.57% | 73.68% |
| EPS Diluted | 26.39% | 27.50% | -200.00% | 86.94% | 73.63% |
| Normalized Diluted EPS | 26.67% | 28.00% | -200.00% | 78.57% | 73.68% |
| Average Basic Shares Outstanding | 3.49% | 7.83% | 62.88% | 62.56% | 57.38% |
| Average Diluted Shares Outstanding | 3.49% | 7.83% | 62.88% | 62.56% | 57.38% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
